Joshua Aiello - 04 Apr 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Principal Accounting Officer
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
04 Apr 2025
Net transactions value
$0
Form type
4
Filing time
04 Apr 2025, 21:40:42 UTC
Previous filing
28 Mar 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +48,000 $0.000000 48,000 04 Apr 2025 Common Stock 48,000 $2.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest as follows: (i) 12,000 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 36,000 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates.